Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Certara, Inc. - Common Stock
(NQ:
CERT
)
10.00
-0.11 (-1.09%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Certara, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
November 21, 2023
Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies
From
Certara
Via
GlobeNewswire
Recap: Certara Q3 Earnings
↗
November 08, 2023
Via
Benzinga
Certara Reports Third Quarter 2023 Financial Results
November 08, 2023
Reiterates Full Year 2023 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
October 11, 2023
From
Certara
Via
GlobeNewswire
The Latest Analyst Ratings for Certara
↗
October 11, 2023
Via
Benzinga
The Latest Analyst Ratings for Certara
↗
August 11, 2023
Via
Benzinga
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
September 19, 2023
Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelines
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
August 29, 2023
From
Certara
Via
GlobeNewswire
Certara Simcyp™ Group Awarded Two New Grants from US FDA
August 29, 2023
Programs focus on use of physiologically-based pharmacokinetic (PBPK) modeling for demonstrating virtual bioequivalence and predicting drug absorption of topical formulations
From
Certara
Via
GlobeNewswire
Looking Into Certara's Return On Capital Employed
↗
May 22, 2023
Via
Benzinga
Analyst Expectations for Certara's Future
↗
April 12, 2023
Via
Benzinga
Expert Ratings for Certara
↗
March 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
↗
August 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
↗
August 10, 2023
Via
Benzinga
Where Certara Stands With Analysts
↗
March 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 10, 2023
Via
Benzinga
Certara Reports Second Quarter 2023 Financial Results
August 09, 2023
Provides Update to Full Year 2023 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
July 13, 2023
From
Certara
Via
GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
June 02, 2023
From
Certara
Via
GlobeNewswire
Certara Reports First Quarter 2023 Financial Results
May 08, 2023
Reiterates 2023 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
April 27, 2023
Asserts Certara’s leadership in advancing the development and approval of new drugs for patients
From
Certara
Via
GlobeNewswire
Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
April 10, 2023
From
Certara
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
↗
April 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
↗
April 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
↗
April 04, 2023
Via
Benzinga
Are These 3 Small Momentum Stocks Setting Up Big Gains?
March 22, 2023
MINISO, PDF Solutions, and Certara are small stocks with strong price momentum. It’s not unusual for small stocks to show more price momentum than larger peers.
Via
MarketBeat
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
↗
March 16, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 16, 2023
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...
Via
Benzinga
A.I. Coming to Certara’s D360 Scientific Informatics Software
March 09, 2023
New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses.
From
Certara
Via
GlobeNewswire
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
March 07, 2023
Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel drugs in lieu of conducting clinical studies
From
Certara
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
